Cargando…
Pharmacogenetics of lipid diseases
The genetic basis for most of the rare lipid monogenic disorders have been elucidated, but the challenge remains in determining the combination of genes that contribute to the genetic variability in lipid levels in the general population; this has been estimated to be in the range of 40-60 per cent...
Autor principal: | Ordovas, Jose M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525073/ https://www.ncbi.nlm.nih.gov/pubmed/15601539 http://dx.doi.org/10.1186/1479-7364-1-2-111 |
Ejemplares similares
-
Pharmacogenetics, pharmacogenomics and airway disease
por: Hall, Ian P
Publicado: (2002) -
The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010) -
Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019) -
Chronic obstructive pulmonary disease: towards pharmacogenetics
por: Wood, Alice M, et al.
Publicado: (2009) -
Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
por: Alonso-Peña, Marta, et al.
Publicado: (2019)